MBCI: coverage initiated

Get your accounts ready for a huge influx of cash. We’re officially opening coverage on MabCure Inc. (MBCI) recently trading around 85 cents a share.

This one has me really excited. Like I said on Friday, this one could double or even triple by weeks end. Yes, we’re looking at the possibility of a HUGE winner in just a matter of days.

Why am I so excited about MBCI?

They’ve developed a way to spot cancer cells so far in advance that the cure rate could be up to 90% to 95%.

MBCI has developed a series of antibodies that can mark cancer cells at their earliest stages, the very next best thing to a full out cure.

Get this: They did a pilot study looking at 13 patients with ovarian cancer—half of which went through chemotherapy. They examined the blood of these patients with the antibodies that they themselves have developed.

Shockingly, the result stunned even skeptics. MabCure’s antibody detected cancer cells remaining in the blood of all 13 patients.

Every other test had missed them. This proves that their antibody was highly sensitive, extremely specific and accurate. Not to mention it gave doctors an advance notice of the patient’s true condition. Truly life saving stuff here!

They also conducted a test of 30 patients with melanoma. One of their antibodies, designed specifically to find these particular cells, did so in 30 out of 30 patients. It correctly identified 100% of the different melanoma cells.

This breakthrough is astonishing and once word hits the street, shares could jump 2, 3 or even 10 fold.

The remarkable characteristic of these antibodies is that they will only seek out specific cancer cells. THIS IS THE FIRST TIME THEY HAVE EVER BEEN CREATED. And they can then produce tens of thousands of these cancer-fighting antibodies with ease.

I can imagine now, going to the drug store to pick up a cancer detecting home-test kit, much like those home pregnancy kits. Again, this stock is trading (ridiculously low) around 85 cents…

Imagine what could happen here folks?

Keep your eyes on MBCI. While there’s a real possibility this stock could jump two or three fold this week alone, we’re going to want to bag 25% on this one, then let some shares ride to the top of the mountain.